ADAG
Adagene Inc
Sign up for free!
Get instant access to stock market data and news with our free APIs.
Real-time data
- Listing exchange
- NASDAQ Stock Exchange
- Price
- $1.87
- Day High
- $1.87
- Day Low
- $1.87
- Day Open
- $1.87
- Volume
- 297
- Day Change
- -2.67%
Latest news data for ADAG
Adagene Announces Interim Data Demonstrating Safety and Confirmed Clinical Responses of Anti-CTLA-4 SAFEbody® ADG126 up to 10 mg/kg with Repeat Cycles in Combination with Anti-PD-1 Therapy from Dose E
asiaone.com
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday’s Mid-Day Session - Adagene (NASDAQ:ADAG), Adobe (NASDAQ:ADBE)
benzinga.com
ADAG stock gains on clinical trial collaboration with Roche (NASDAQ:ADAG)
seekingalpha.com
Adagene Announces Clinical Trial Collaboration to Evaluate Anti-CTLA-4 SAFEbody® ADG126 in Combination with Roche’s Standard-of-Care for First-Line Advanced Liver Cancer
asiaone.com
Adagene Appoints Cuong Do to Board of Directors and Audit Committee
asiaone.com
Adagene Announces Clinical Data at SITC 2022 on Anti-CTLA-4 NEObody™, ADG116, Showing Differentiated Safety and Anti-tumor Activity in Heavily Pre-treated Patients with Difficult-to-Treat Tumors
asiaone.com
Adagene Inc. (NASDAQ:ADAG) Sees Significant Increase in Short Interest
etfdailynews.com
Adagene Announces Poster Presentations on Anti-CTLA-4 NEObody™, ADG116, at Upcoming Society for Immunotherapy of Cancer’s (SITC) Annual Meeting in November, Business News
asiaone.com
Adagene Inc. (NASDAQ:ADAG) Sees Significant Drop in Short Interest
etfdailynews.com
Adagene Inc. (NASDAQ:ADAG) Short Interest Down 21.1% in August
etfdailynews.com